Shanghai Pharmaceuticals Holding Co., Ltd (HKG:2607)
12.16
+0.09 (0.75%)
At close: Dec 5, 2025
HKG:2607 Market Cap
HKG:2607 has a market cap or net worth of 66.15 billion as of December 5, 2025. Its market cap has decreased by -9.18% in one year.
Market Cap
66.15B
Enterprise Value
97.20B
Revenue
306.77B
Ranking
n/a
PE Ratio
10.72
Stock Price
12.16
Market Cap Chart
Since August 20, 2004, HKG:2607's market cap has increased from 2.31B to 66.15B, an increase of 2,762.54%. That is a compound annual growth rate of 17.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 66.15B | -10.42% |
| Dec 31, 2024 | 73.85B | 19.47% |
| Dec 29, 2023 | 61.81B | -8.98% |
| Dec 30, 2022 | 67.91B | 12.28% |
| Dec 31, 2021 | 60.49B | 7.24% |
| Dec 31, 2020 | 56.40B | 5.52% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 291.02B |
| Hansoh Pharmaceutical Group Company | 243.25B |
| JD Health International | 192.57B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 135.64B |
| Sino Biopharmaceutical | 122.99B |
| Akeso | 113.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |